Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project, a database of genetic data that is expected to accelerate ...

Truveta, a health data startup launched in 2020, announced the massive undertaking Jan. 13 along with biotech firm Illumina and the Regeneron Genetics Center, an arm of Fortune 500 company Regeneron ...

Seventeen health systems are investing in a genomic database that could significantly drive down clinical costs. Truveta, a Washington-based software company, unveiled the Truveta Genome Project on ...

Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research. Regeneron's $119.5 million investment in Truveta's Series ...

NEW YORK, Jan 13 (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals (REGN.O), opens new tab, Illumina (ILMN.O), opens new ...

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and more.

Regeneron will provide a strategic investment of $119.5 million as part of Truveta’s Series C financing round and collaborate with Truveta to launch the Truveta Genome Project.